In agreement with this, microarray phosphatome profiling of BC patients has shown that DUSP10 is over-expressed in a specific BC genetic profile, with both estrogen receptor (ER)-negative and epidermal grown factor receptor 2 overexpressing BC [58]. Here, DUSP10 is linked to breast cancer.